HK1200169A1 - Compounds used in the synthesis of oxazolidinones - Google Patents
Compounds used in the synthesis of oxazolidinonesInfo
- Publication number
- HK1200169A1 HK1200169A1 HK15100600.5A HK15100600A HK1200169A1 HK 1200169 A1 HK1200169 A1 HK 1200169A1 HK 15100600 A HK15100600 A HK 15100600A HK 1200169 A1 HK1200169 A1 HK 1200169A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxazolidinones
- synthesis
- compounds used
- compounds
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10446908P | 2008-10-10 | 2008-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1200169A1 true HK1200169A1 (en) | 2015-07-31 |
Family
ID=41382395
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100600.5A HK1200169A1 (en) | 2008-10-10 | 2015-01-19 | Compounds used in the synthesis of oxazolidinones |
| HK17105843.9A HK1232221A1 (zh) | 2008-10-10 | 2017-06-13 | 製備噁唑烷酮類的方法及含有噁唑烷酮類的組合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK17105843.9A HK1232221A1 (zh) | 2008-10-10 | 2017-06-13 | 製備噁唑烷酮類的方法及含有噁唑烷酮類的組合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8604209B2 (ru) |
| EP (2) | EP2757104B1 (ru) |
| JP (1) | JP5773875B2 (ru) |
| KR (1) | KR101674146B1 (ru) |
| CN (2) | CN102177156B (ru) |
| AU (1) | AU2009303301B2 (ru) |
| CA (1) | CA2738671C (ru) |
| ES (2) | ES2748505T3 (ru) |
| HK (2) | HK1200169A1 (ru) |
| MX (2) | MX366793B (ru) |
| RU (2) | RU2556234C2 (ru) |
| SG (2) | SG10201702946RA (ru) |
| WO (1) | WO2010042887A2 (ru) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| WO2010042887A2 (en) | 2008-10-10 | 2010-04-15 | Trius Therapeutics | Methods for preparing oxazolidinones and compositions containing them |
| AU2010210627B2 (en) | 2009-02-03 | 2016-03-03 | Merck Sharp & Dohme Llc | Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
| US20120065170A1 (en) | 2010-09-10 | 2012-03-15 | Micurx Pharmaceuticals, Inc. | Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections |
| WO2016009401A2 (en) * | 2014-07-18 | 2016-01-21 | Dr. Reddy's Laboratories Limited | Preparation of tedizolid phosphate |
| CN105367547B (zh) * | 2014-08-19 | 2019-04-23 | 北京桦冠生物技术有限公司 | 一种噁唑啉酮抗生素的新合成工艺 |
| CN106928214A (zh) * | 2014-09-17 | 2017-07-07 | 博瑞生物医药（苏州）股份有限公司 | 一种噁唑烷酮类化合物及其中间体的制备方法 |
| WO2016041505A1 (zh) * | 2014-09-17 | 2016-03-24 | 正大天晴药业集团股份有限公司 | 一种磷酸特地唑胺、其中间体以及它们的制备方法 |
| CN104327119A (zh) * | 2014-10-17 | 2015-02-04 | 苏州明锐医药科技有限公司 | 磷酸泰地唑胺的制备方法 |
| WO2016088102A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | Processes for the preparation of tedizolid phosphate and its intermediates |
| WO2016088100A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | Processes for the preparation of tedizolid phosphate and its intermediates |
| WO2016088103A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | A process for the preparation of tedizolid phosphate |
| WO2016088101A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | Processes for the preparation of tedizolid phosphate and its intermediates |
| CN104558034A (zh) * | 2015-01-21 | 2015-04-29 | 齐鲁制药有限公司 | 磷酸特地唑胺二钠盐的新晶型及其制备方法 |
| CN105837634B (zh) * | 2015-01-30 | 2020-09-04 | 上海创诺制药有限公司 | 一种泰地唑胺磷酸酯结晶体及其制备方法 |
| CN104592218B (zh) * | 2015-02-13 | 2015-11-04 | 江苏欧信医药化工有限公司 | 一种泰地唑胺的合成方法 |
| CN104892592A (zh) * | 2015-03-30 | 2015-09-09 | 成都惟新医药科技有限公司 | 一种泰地唑胺的制备方法 |
| CN106146485B (zh) * | 2015-04-01 | 2021-04-30 | 上海迪赛诺化学制药有限公司 | 一种制备泰地唑胺的方法及其得到的泰地唑胺结晶体 |
| CN106279281B (zh) * | 2015-05-15 | 2018-08-03 | 重庆圣华曦药业股份有限公司 | 噁唑烷酮类抗菌素泰地唑胺磷酸酯的精制方法 |
| CN106279282B (zh) * | 2015-05-21 | 2019-08-23 | 博瑞生物医药（苏州）股份有限公司 | 一种磷酸特地唑胺的纯化方法 |
| CN106317114B (zh) * | 2015-07-02 | 2018-11-20 | 南京优科制药有限公司 | 一种磷酸特地唑胺的制备方法 |
| CN105131037B (zh) * | 2015-07-28 | 2017-05-03 | 济南爱思医药科技有限公司 | 一种高纯度泰地唑胺磷酸酯的制备方法 |
| CN106632298B (zh) * | 2015-11-03 | 2021-06-01 | 上海科胜药物研发有限公司 | 一种泰地唑胺的制备方法及其中间体 |
| KR101855334B1 (ko) | 2015-12-11 | 2018-06-08 | 에스티팜 주식회사 | 옥사졸리디논 유도체의 중간체 제조방법 |
| CN105418681A (zh) * | 2015-12-15 | 2016-03-23 | 南京艾德凯腾生物医药有限责任公司 | 一种磷酸特地唑胺的制备方法 |
| CN107488188B (zh) * | 2016-06-12 | 2019-03-15 | 重庆圣华曦药业股份有限公司 | 一种制备特地唑胺关键中间体的合成方法 |
| CN106146560B (zh) * | 2016-07-12 | 2019-02-01 | 扬子江药业集团有限公司 | 一种高纯度磷酸特地唑胺的精制方法 |
| CN106432182B (zh) * | 2016-09-06 | 2019-04-30 | 铜仁学院 | 特地唑胺中间体的合成方法 |
| CN106565680A (zh) * | 2016-10-31 | 2017-04-19 | 瑞阳制药有限公司 | 特地唑胺杂质及其制备方法 |
| CN108059624A (zh) * | 2016-11-08 | 2018-05-22 | 上海医药工业研究院 | 用于制备咔哒唑胺关键中间体的制备方法 |
| CN106632240A (zh) * | 2016-11-25 | 2017-05-10 | 山东轩德医药科技有限公司 | 一种2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法 |
| CN106699730A (zh) * | 2016-12-23 | 2017-05-24 | 山东轩德医药科技有限公司 | 2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法 |
| CN107722056A (zh) * | 2017-10-31 | 2018-02-23 | 重庆华邦胜凯制药有限公司 | 磷酸特地唑胺的制备方法 |
| US11452719B2 (en) | 2017-12-13 | 2022-09-27 | Merck Sharp & Dohme Llc | Pharmaceutical compositions of tedizolid phosphate |
| CN110804038B (zh) * | 2018-08-06 | 2021-03-05 | 上海博志研新药物技术有限公司 | 磷酸特地唑胺及其中间体的制备方法 |
| CN110938058B (zh) * | 2018-09-22 | 2022-04-12 | 南京优科生物医药研究有限公司 | 一种噁唑烷酮类抗生素中间体的制备方法 |
| CN111116652A (zh) * | 2019-12-06 | 2020-05-08 | 山东中医药大学 | 一种高纯度磷酸特地唑胺的制备方法 |
| CN113121518B (zh) * | 2019-12-31 | 2022-06-28 | 北京福元医药股份有限公司 | 一种特地唑胺杂质的制备方法 |
| CN111285848A (zh) * | 2020-04-10 | 2020-06-16 | 苏州敬业医药化工有限公司 | 一种5-溴-2-(2-甲基-2h-四唑-5-基)吡啶的纯化方法 |
| BR112022025918A2 (pt) | 2020-06-18 | 2023-03-14 | Akagera Medicines Inc | Compostos de oxazolidinona, composições lipossomais que compreendem compostos de oxazolidinona e métodos de uso dos mesmos |
| CN114105946A (zh) * | 2020-08-26 | 2022-03-01 | 浙江苏泊尔制药有限公司 | 一种磷酸特地唑胺中间体及其制备方法 |
| CN112961186A (zh) * | 2021-02-04 | 2021-06-15 | 海南通用康力制药有限公司 | 一种磷酸特地唑胺的纯化方法 |
| CN113248471B (zh) * | 2021-07-05 | 2021-09-21 | 南京桦冠生物技术有限公司 | 一种唑胺类药物中间体的制备方法及其中间体 |
| CN113488445A (zh) * | 2021-07-05 | 2021-10-08 | 合肥巨一动力系统有限公司 | 一种igbt封装散热结构及其应用的电机控制器 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU80081A1 (fr) | 1977-08-26 | 1979-05-15 | Delalande Sa | Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique |
| US4128654A (en) | 1978-02-10 | 1978-12-05 | E. I. Du Pont De Nemours And Company | 5-Halomethyl-3-phenyl-2-oxazolidinones |
| US4340606A (en) | 1980-10-23 | 1982-07-20 | E. I. Du Pont De Nemours And Company | 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents |
| FR2500450A1 (fr) | 1981-02-25 | 1982-08-27 | Delalande Sa | Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique |
| US4461773A (en) | 1982-09-15 | 1984-07-24 | E. I. Dupont De Nemours And Company | P-Oxooxazolidinylbenzene compounds as antibacterial agents |
| CA1320730C (en) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| US4948801A (en) | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| CA2119556C (en) | 1991-11-01 | 2004-07-06 | Michael Robert Barbachyn | Substituted aryl- and heteroaryl-phenyloxazolidinones |
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| ATE161833T1 (de) | 1992-12-08 | 1998-01-15 | Upjohn Co | Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| US5652238A (en) | 1993-11-22 | 1997-07-29 | Pharmacia & Upjohn Company | Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| US6413981B1 (en) * | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| EP1289984A4 (en) | 2000-06-05 | 2004-11-24 | Dong A Pharm Co Ltd | NEW OXAZOLIDE DERIVATIVES AND A METHOD FOR THEIR PRODUCTION |
| US20020115669A1 (en) | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
| ES2268011T3 (es) | 2001-04-07 | 2007-03-16 | Astrazeneca Ab | Oxazolidinonas que contienen un grupo sulfonimida como antibioticos. |
| US6627646B2 (en) | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| PT1427711E (pt) | 2001-09-11 | 2005-11-30 | Astrazeneca Ab | Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos |
| US20050043374A1 (en) | 2001-10-25 | 2005-02-24 | Gravestock Michael Barry | Aryl substituted oxazolidinones with antibacterial activity |
| NZ515881A (en) | 2001-12-03 | 2004-09-24 | New Zealand Dairy Board | Cheese flavour ingredient and method of its production |
| BR0308056A (pt) | 2002-02-28 | 2004-12-07 | Astrazeneca Ab | Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto |
| NZ535591A (en) | 2002-02-28 | 2006-07-28 | Astrazeneca Ab | Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| US7223870B2 (en) | 2002-11-01 | 2007-05-29 | Pfizer Inc. | Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| CA2507628A1 (en) | 2002-11-28 | 2004-06-10 | Astrazeneca Ab | Oxazolidinones as antibacterial agents |
| AU2003302404B2 (en) | 2002-11-28 | 2008-06-19 | Astrazeneca Ab | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| GB0229518D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| TW200500360A (en) | 2003-03-01 | 2005-01-01 | Astrazeneca Ab | Hydroxymethyl compounds |
| GB0306358D0 (en) * | 2003-03-20 | 2003-04-23 | Astrazeneca Ab | Chemical compounds |
| KR20060113625A (ko) | 2003-07-02 | 2006-11-02 | 머크 앤드 캄파니 인코포레이티드 | 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체 |
| AU2004256085B2 (en) | 2003-07-02 | 2007-12-06 | Kyorin, Pharmaceutical Co., Ltd. | Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof |
| WO2005051933A1 (en) | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby |
| TW200526649A (en) | 2003-12-17 | 2005-08-16 | Rib X Pharmaceuticals Inc | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| US20070191336A1 (en) | 2003-12-24 | 2007-08-16 | Flynn Daniel L | Anti-inflammatory medicaments |
| GB0411596D0 (en) | 2004-05-25 | 2004-06-30 | Astrazeneca Ab | Chemical process |
| JP2008500317A (ja) | 2004-05-25 | 2008-01-10 | アストラゼネカ アクチボラグ | 抗菌剤としての３−’４−｛６−置換アルカノイル）ピリジン−３−イル｝−３−フェニル−５−（１ｈ−１，２，３−トリアゾール−１−イルメチル）−１，３−オキサゾリジン−２−オン |
| US20080064689A1 (en) | 2004-05-25 | 2008-03-13 | Astrazeneca Ab | 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents |
| CA2567457A1 (en) | 2004-05-25 | 2005-12-08 | Astrazeneca Ab | 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections |
| WO2005116023A1 (en) | 2004-05-25 | 2005-12-08 | Astrazeneca Ab | 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
| EP1799677A1 (en) | 2004-10-08 | 2007-06-27 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| EP1912980A2 (en) * | 2005-06-20 | 2008-04-23 | Wockhardt Limited | Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| WO2007138381A2 (en) | 2005-10-14 | 2007-12-06 | Targanta Therapeutics Inc. | Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections |
| CN101720325B (zh) | 2007-08-06 | 2013-04-24 | 上海盟科药业有限公司 | 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮 |
| WO2010042887A2 (en) | 2008-10-10 | 2010-04-15 | Trius Therapeutics | Methods for preparing oxazolidinones and compositions containing them |
| AU2010210627B2 (en) | 2009-02-03 | 2016-03-03 | Merck Sharp & Dohme Llc | Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
-
2009
- 2009-10-09 WO PCT/US2009/060267 patent/WO2010042887A2/en active Application Filing
- 2009-10-09 KR KR1020117010217A patent/KR101674146B1/ko active IP Right Grant
- 2009-10-09 CN CN200980140144.4A patent/CN102177156B/zh active Active
- 2009-10-09 RU RU2011115109/04A patent/RU2556234C2/ru active
- 2009-10-09 RU RU2015122033A patent/RU2659792C1/ru active
- 2009-10-09 ES ES09749235T patent/ES2748505T3/es active Active
- 2009-10-09 ES ES14159112T patent/ES2744907T3/es active Active
- 2009-10-09 MX MX2014004600A patent/MX366793B/es unknown
- 2009-10-09 MX MX2011003820A patent/MX2011003820A/es active IP Right Grant
- 2009-10-09 US US12/577,089 patent/US8604209B2/en active Active
- 2009-10-09 CN CN201610581761.XA patent/CN106220621B/zh active Active
- 2009-10-09 CA CA2738671A patent/CA2738671C/en active Active
- 2009-10-09 SG SG10201702946RA patent/SG10201702946RA/en unknown
- 2009-10-09 SG SG2013075965A patent/SG195544A1/en unknown
- 2009-10-09 AU AU2009303301A patent/AU2009303301B2/en active Active
- 2009-10-09 EP EP14159112.3A patent/EP2757104B1/en active Active
- 2009-10-09 EP EP09749235.9A patent/EP2346858B1/en active Active
- 2009-10-09 JP JP2011531233A patent/JP5773875B2/ja active Active
-
2013
- 2013-11-25 US US14/089,050 patent/US9328087B2/en active Active
-
2015
- 2015-01-19 HK HK15100600.5A patent/HK1200169A1/xx unknown
-
2017
- 2017-06-13 HK HK17105843.9A patent/HK1232221A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2738671C (en) | 2018-05-01 |
| ES2744907T3 (es) | 2020-02-26 |
| MX366793B (es) | 2019-07-24 |
| KR20110071107A (ko) | 2011-06-28 |
| WO2010042887A2 (en) | 2010-04-15 |
| HK1232221A1 (zh) | 2018-01-05 |
| CA2738671A1 (en) | 2010-05-15 |
| EP2346858A2 (en) | 2011-07-27 |
| AU2009303301B2 (en) | 2014-09-11 |
| RU2659792C1 (ru) | 2018-07-04 |
| EP2757104A1 (en) | 2014-07-23 |
| CN106220621A (zh) | 2016-12-14 |
| RU2011115109A (ru) | 2012-11-20 |
| EP2346858B1 (en) | 2019-08-07 |
| EP2757104B1 (en) | 2019-08-14 |
| KR101674146B1 (ko) | 2016-11-08 |
| ES2748505T3 (es) | 2020-03-17 |
| JP2012505252A (ja) | 2012-03-01 |
| SG195544A1 (en) | 2013-12-30 |
| SG10201702946RA (en) | 2017-05-30 |
| US8604209B2 (en) | 2013-12-10 |
| CN102177156B (zh) | 2016-08-24 |
| US9328087B2 (en) | 2016-05-03 |
| MX2011003820A (es) | 2011-06-16 |
| US20140206878A1 (en) | 2014-07-24 |
| AU2009303301A1 (en) | 2010-04-15 |
| WO2010042887A3 (en) | 2010-06-24 |
| JP5773875B2 (ja) | 2015-09-02 |
| RU2556234C2 (ru) | 2015-07-10 |
| CN106220621B (zh) | 2019-06-11 |
| CN102177156A (zh) | 2011-09-07 |
| US20100093669A1 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1200169A1 (en) | Compounds used in the synthesis of oxazolidinones | |
| HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
| IL254218A0 (en) | Pipedrine-bridged compounds of the quinoxaline-converted type and their use | |
| HK1139936A1 (en) | Substituted pyrimidodiazepines useful as plk1 inhibitors | |
| EP2251403A4 (en) | CLEANING SUPPLIES | |
| IL212590A0 (en) | New compounds 578 | |
| HK1179514A1 (en) | Composition for external use | |
| HK1154794A1 (en) | Liquid oral composition | |
| GB0808708D0 (en) | New compounds 274 | |
| GB0808707D0 (en) | New compounds 275 | |
| ZA201103888B (en) | Novel use | |
| GB0823366D0 (en) | Synthesis | |
| GB0800414D0 (en) | Novel use | |
| PL384700A1 (pl) | Sposób syntezy 1-propenyloksyalkoholu | |
| GB0803103D0 (en) | Novel compounds 3 | |
| GB0811131D0 (en) | Novel compounds 336 | |
| GB0823010D0 (en) | Novel use | |
| GB0822377D0 (en) | Novel use | |
| GB0807162D0 (en) | Novel use | |
| GB0814821D0 (en) | Novel use | |
| GB0805046D0 (en) | Novel use | |
| GB0801110D0 (en) | Synthesis | |
| GB0813324D0 (en) | New compounds 3 | |
| GB0807658D0 (en) | Sebaforce 2 |